title: Cancer drugs can be four times more costly in some wealthy countries than in others.
authors.affiliation: The BMJ.
authors.forename: Zosia
authors.initials: Z
authors.lastname: Kmietowicz
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000191:economics; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D001315:Australia; D017281:Cost of Illness; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000191:economics; D019049:Developed Countries; D004345:Drug Industry / Q000191:economics*; D005062:European Union; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics*; D009520:New Zealand; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003841:Deoxycytidine; D000093542:Gemcitabine